Stockscreener 앱 받기
26.69
1.48%
0.39
시간 외 거래:
26.17
-0.52
-1.95%
전일 마감가:
$26.30
열려 있는:
$26.32
하루 거래량:
851.48K
Relative Volume:
1.10
시가총액:
$1.35B
수익:
$534.53M
순이익/손실:
$-11.45M
주가수익비율:
-110.70
EPS:
-0.2411
순현금흐름:
$48.28M
1주 성능:
-9.19%
1개월 성능:
-5.46%
6개월 성능:
-19.27%
1년 성능:
-16.10%
1일 변동 폭
$26.14
$27.02
1주일 범위
$25.52
$29.34
52주 변동 폭
$25.52
$43.18
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
26.69 | 1.33B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-18 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2026-02-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook - Yahoo Finance
ATRC: Innovation, clinical trials, and new launches drive growth and reinforce market leadership - TradingView
Transcript : AtriCure, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10 - marketscreener.com
Responsive Playbooks and the ATRC Inflection - Stock Traders Daily
Number of shareholders of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Number of shareholders of AtriCure, Inc. – DUS:A5I - TradingView
Assessing AtriCure (ATRC) Valuation After A Prolonged Share Price Decline - Yahoo Finance
AtriCure Inc stock hits 52-week low at 26.62 USD - Investing.com India
AtriCure Inc stock hits 52-week low at 26.62 USD By Investing.com - Investing.com Nigeria
AtriCure, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:ATRC) 2026-05-08 - Seeking Alpha
AtriCure (ATRC) Q1 Breakeven EPS Tests Bullish Profitability Narrative - Sahm
AtriCure : Investor Presentation Q1 2026 vF - marketscreener.com
AtriCure Q1 Loss Narrows, Revenue Increases; 2026 Guidance Maintained - Moomoo
AtriCure, Inc. (NASDAQ:ATRC) Q1 2026 Earnings Call Transcript - Insider Monkey
AtriCure Earnings Call Highlights Profitable Growth Pivot - TipRanks
AtriCure Price Target Raised to $55.00/Share From $53.00 by Canaccord Genuity - Moomoo
AtriCure, Inc. 1Q 2026: Revenue $141.25M, EPS $0— 10-Q Summary - TradingView
AtriCure (NASDAQ: ATRC) posts Q1 2026 growth, swings to profit - Stock Titan
Stifel Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $50 - Moomoo
AtriCure reiterates 2026 revenue $600M-$610M as BoxX-NoAF enrollment targets year-end completion - MSN
AtriCure (ATRC) reports break-even earnings for Q1 - MSN
AtriCure (ATRC) Q1 2026 Earnings Transcript - The Globe and Mail
AtriCure Q1 2026 revenue up 14.3% to USD 141.2M - Medical Buyer
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Raises Target Price to $55 - Moomoo
Needham reiterates Buy on AtriCure stock after Q1 beat - Investing.com UK
BTIG Maintains AtriCure(ATRC.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
AtriCure, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Needham Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45 - Moomoo
AtriCure | 8-K/A: AtriCure Reports First Quarter 2026 Financial Results - Moomoo
Needham reiterates Buy on AtriCure stock after Q1 beat By Investing.com - Investing.com India
AtriCure (ATRC) posts 14% Q1 revenue growth and sets 2026 EPS, EBITDA targets - Stock Titan
AtriCure Q1 2026 Earnings Call Transcript - MarketBeat
AtriCure Reports First Quarter 2026 Financial Results - BioSpace
Transcript : AtriCure, Inc., Q1 2026 Earnings Call, May 05, 2026 - marketscreener.com
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q1 Earnings - Yahoo Finance
Earnings call transcript: AtriCure Q1 2026 reports strong revenue growth By Investing.com - Investing.com Australia
AtriCure Q1 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: AtriCure Q1 2026 reports strong revenue growth - Investing.com
AtriCure (ATRC) Reports Break-Even Earnings for Q1 - Yahoo Finance
AtriCure Inc reports results for the quarter ended March 31Earnings Summary - TradingView
AtriCure (NASDAQ:ATRC) Q1 Results Beat Estimates as Company Reaches Key Profitability Milestone - ChartMill
AtriCure Inc. (ATRC) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Q1 2026 AtriCure Inc Earnings Call Transcript - GuruFocus
AtriCure Sees 2026 Rev $600M-$610M >ATRC - Moomoo
Earnings Flash (ATRC) AtriCure, Inc. Reports Q1 Revenue $141.2M, vs. FactSet Est of $139.7M - marketscreener.com
Earnings Flash (ATRC) AtriCure, Inc. Posts Q1 Adjusted EPS $0.00 per Share, vs. FactSet Est of $-0.06 - marketscreener.com
AtriCure (NASDAQ: ATRC) Q1 2026 revenue jumps 14% to $141M - Stock Titan
Earnings Flash (ATRC) AtriCure, Inc. Posts Q1 Adjusted EPS $0.00 per Share, Vs. FactSet Est of $-0.06 - Moomoo
Press Release: AtriCure Reports First Quarter 2026 Financial Results - Moomoo
AtriCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
AtriCure (ATRC) Slid Despite Strong Earnings - Insider Monkey
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.05%
3.17%
자본화:
|
볼륨(24시간):